Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Frequently asked questions
What sector does Rafarma Pharmaceuticals Inc (RAFA) operate in?
Rafarma Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Rafarma Pharmaceuticals Inc (RAFA) current stock price?
As of the latest data, Rafarma Pharmaceuticals Inc stock price is $0.01, with a previous close of $0.01.
What is Rafarma Pharmaceuticals Inc (RAFA) current market capitalization?
Rafarma Pharmaceuticals Inc market cap is approximately 1.23 million.
What is Rafarma Pharmaceuticals Inc (RAFA) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
What is Rafarma Pharmaceuticals Inc (RAFA) EBITDA?
Rafarma Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 88.00 thousand.
Does Rafarma Pharmaceuticals Inc (RAFA) pay dividends?
No. Rafarma Pharmaceuticals Inc does not pay a dividend.
What is Rafarma Pharmaceuticals Inc (RAFA) beta (volatility) score?
Rafarma Pharmaceuticals Inc has a beta of 0.720, indicating lower volatility than the overall market.
